Opportunity Information: Apply for RFA AG 24 019

This National Institutes of Health (NIH) funding opportunity, RFA-AG-24-019, supports R01 research projects that use comparative approaches across humans and nonhuman primates to understand why different primate species have different life spans, life histories, and aging-related outcomes. The central idea is that primates vary widely in longevity and patterns of aging, and those natural differences can be used as a kind of biological experiment to pinpoint mechanisms that may shape life span (how long a species tends to live) and health span (how long individuals remain relatively healthy and functional). A major emphasis is on identifying factors that vary across species and could help explain why humans generally live longer than many other primates, although the scope is not limited to that question alone.

The FOA invites studies that generate new data or make strong use of existing resources. Applicants can propose primary in vivo or in vitro work (for example, biological measurements collected directly from organisms or cells) as well as analyses of existing datasets and/or previously collected biospecimens. In practice, that means a project could involve new laboratory assays, comparative molecular or physiological profiling, or careful re-analysis of archived samples and longitudinal records from primate research colonies, field studies, or human cohorts, as long as the comparative design is clearly aimed at understanding cross-species differences tied to aging, longevity, and related life-history traits.

Because the opportunity is framed around “prospects for translation,” the NIH is looking for proposals that do more than just describe species differences. The expectation is that applicants will connect comparative findings to hypotheses about mechanisms that could eventually inform human aging biology and interventions. Translation here does not necessarily mean immediate clinical application; it can also mean identifying conserved pathways, protective adaptations, or modifiable risk factors suggested by primate comparisons that merit follow-up in human studies or preclinical models.

This is an R01 mechanism, which typically supports substantial, multi-year research programs with well-developed aims, rigorous methods, and strong analytical plans. The announcement explicitly states “Clinical Trial Not Allowed,” which generally means the proposed research should not include prospective assignment of human participants to interventions to evaluate health outcomes as a clinical trial. Applicants can still use human data, biospecimens, and observational designs, but they need to stay within the NIH definition boundaries that separate mechanistic or observational studies from clinical trials.

Eligibility is broad and includes many types of domestic and international organizations. Eligible applicants include state, county, and local governments; special districts; independent school districts; public and state-controlled universities; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (including small businesses and other for-profits); and other categories. The FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, non-U.S. entities (foreign organizations), and U.S. territories or possessions. This broad eligibility is intended to encourage diverse institutional participation and to leverage unique primate, human, and biobank resources that may be distributed across many settings.

From the posted details, the sponsoring agency is NIH, the activity category is Health, and the CFDA/Assistance Listing number is 93.866. The original closing date listed is 2023-09-27, and the opportunity was created on 2023-02-10. No award ceiling or expected number of awards is specified in the provided summary, so applicants would typically consult the full FOA text and NIH budget guidance for the most accurate funding expectations, allowable costs, and any institute-specific priorities tied to aging research.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Comparative Research on Determinants of Differences Among Human and Nonhuman Primate Species in Life Spans, Life Histories, and Other Aging-Related Outcomes, and Prospects for Translation (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2023-02-10.
  • Applicants must submit their applications by 2023-09-27. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 24 019

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: BJA FY 23 Community Courts Initiative

Previous opportunity: Cooperative Agreement for CESU-affiliated Partner with Rocky Mountain Cooperative Ecosystem Studies Unit

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 24 019

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 24 019) also looked into and applied for these:

Funding Opportunity
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) Apply for PAR 23 100

Funding Number: PAR 23 100
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Expand Family Planning and Sexual and Reproductive Health Activity (ExpandPF) Apply for RFI 624 23 00001

Funding Number: RFI 624 23 00001
Agency: West Africa USAID-Ghana
Category: Health
Funding Amount: $45,000,000
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) Apply for PAR 23 099

Funding Number: PAR 23 099
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) Apply for PAR 23 106

Funding Number: PAR 23 106
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional) Apply for RFA MD 23 004

Funding Number: RFA MD 23 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Preventions (R18) Apply for RFA HS 23 011

Funding Number: RFA HS 23 011
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
Dissemination and Implementation of Equity-Focused Evidence-Based Interventions in Healthcare Delivery Systems (R18) Apply for RFA HS 23 002

Funding Number: RFA HS 23 002
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $2,500,000
AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for RFA HS 23 010

Funding Number: RFA HS 23 010
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
Supporting the Management of Substance Use Disorders in Primary Care and other Ambulatory Settings (R18) Apply for RFA HS 23 005

Funding Number: RFA HS 23 005
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $625,000
Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) Apply for RFA AI 23 015

Funding Number: RFA AI 23 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,850,000
Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed) Apply for RFA MH 23 275

Funding Number: RFA MH 23 275
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional) Apply for RFA AT 24 001

Funding Number: RFA AT 24 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $600,000
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) Apply for RFA AG 24 014

Funding Number: RFA AG 24 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) Apply for RFA AG 24 015

Funding Number: RFA AG 24 015
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed) Apply for PAR 23 265

Funding Number: PAR 23 265
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) Apply for PAR 23 263

Funding Number: PAR 23 263
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed) Apply for PAR 23 266

Funding Number: PAR 23 266
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Roybal Centers for Translational Behavioral Research on Dementia Care, Caregiver Support, and Prevention of Alzheimers Disease and Related Dementias (AD/ADRD) (P30 Clinical Trial Required) Apply for RFA AG 24 007

Funding Number: RFA AG 24 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Edward R. Roybal Coordinating Center (R24 - Clinical Trial Not Allowed) Apply for RFA AG 24 008

Funding Number: RFA AG 24 008
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Roybal Centers for Translational Research on Aging (P30 Clinical Trial Required) Apply for RFA AG 24 006

Funding Number: RFA AG 24 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 019", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: